Florida Society of Clinical Oncology
The Voice of Oncology in Florida
Menu
Flasco Patient Portal
Become a Member
FLASCO Meetings
Search the Florida Society of Clinical Oncology Website
SEARCH
Menu
Home
About
Profile & Mission
History
Board of Directors & Liaisons
Committees
A Year in Review
FLASCO Staff
FLASCO Oncology Captains
Membership
Benefits
Become a Member
Become a Corporate Partner
Professional Partnership Program
Corporate Partners
Events
Calendar of Events
FLASCO Events
Events
Webinars
Past Events
Advocacy
Find Your Legislator
News & Updates
Administrator Network Updates
Clinical Trials
Drugs
FLASCO News
FLASCO eNewsletter
FLASCO OncoFeatures
Legislative Updates
Member Publications
For Professionals
Professional Associations
Resources
Podcasts
Job Board
Contact
FDA approves new indication for Gilotrif® in EGFR mutation-positive NSCLC
January 18, 2018
Drugs
,
News
© 2021 FLASCO |
Premium Website Design
by
The HDG
Home
About
Profile & Mission
History
Board of Directors & Liaisons
Committees
A Year in Review
FLASCO Staff
FLASCO Oncology Captains
Back
Membership
Benefits
Become a Member
Become a Corporate Partner
Professional Partnership Program
Corporate Partners
Back
Events
Calendar of Events
FLASCO Events
Events
Webinars
Past Events
Back
Advocacy
Find Your Legislator
Back
News & Updates
Administrator Network Updates
Clinical Trials
Drugs
FLASCO News
FLASCO eNewsletter
FLASCO OncoFeatures
Legislative Updates
Member Publications
Back
For Professionals
Professional Associations
Resources
Podcasts
Job Board
Back
Contact
Flasco Patient Portal
Become a Member
FLASCO Meetings
× Close Panel
